Congress has set a target date of June 29 for final passage of this comprehensive legislation, which includes a number of measures beneficial for the rare disease community. The EXPERRT Act aims to promote collaboration between
Through greater collaboration, improved access to rare disease expertise, and more efficient drug review channels, breakthrough new treatments can more quickly reach people with cystic fibrosis and others with rare diseases.